Visit-to-Visit Heart Rate Variability in the Prediction of Clinical Outcomes of Patients with Atrial Fibrillation

Rungroj Krittayaphong; Warangkna Boonyapisit; Poom Sairat; Professor Gregory Lip

doi:10.1055/s-0043-1768580

Abstract

1 min read

VVV-HR is an independent predictor for adverse clinical outcomes in patients with AF. A <i>J</i>-curve appearance was demonstrated for the effect of VVV-HR on all-cause death.

Related publications

Letter2021

Clinical outcomes with digoxin vs. beta‐blocker for heart rate control in permanent atrial fibrillation with heart failure

Arnaud Bisson, Wern Yew Ding, Alexandre Bodin, Professor Gregory Lip, Laurent Fauchier

Article2025

Outcomes in Atrial Fibrillation Patients with Different Clinical Phenotypes: Insights from the French Population

Ameenathul M. Fawzy, Arnaud Bisson, Lisa Lochon, Thibault Lenormand, Professor Gregory Lip, Laurent Fauchier

Article2021

Are the results of the RATE-AF trial reproducible in daily practice? Clinical outcomes with digoxin vs beta-blocker for heart rate control in permanent atrial fibrillation

Laurent Fauchier, Arnaud Bisson, Alexandre Bodin, P Spiesser, Nicolas Clémenty, Bernard Pierre, D Babuty, Professor Gregory Lip

Article2024

Adverse Events and Clinical Correlates in Asian Patients with Atrial Fibrillation and Diabetes Mellitus: A Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry

Tommaso Bucci, Katarzyna Nabrdalik, Alena Shantsila, Giulio Francesco Romiti, Wee‐Siong Teo, Hyung Wook Park, Wataru Shimizu, Hung‐Fat Tse, Marco Proietti, Tze‐Fan Chao, Professor Gregory Lip

Article2022

Anaemia and adverse outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general long-term registry

Giuseppe Boriani, M Vitolo, Marco Proietti, V L Malavasi, N Bonini, G F Romiti, J F Imberti, L Fauchier, Michael Näbauer, Tatjana Potpara, Gheorghe‐Andrei Dan, Zbigniew Kalarus, Aldo Maggioni, Deirdre A. Lane, G Y H Lip